CMIIU
Get informed when a big investor buys or sells
+ FollowOvervalued by 122.3% based on the discounted cash flow analysis.
| Market cap | $396.23 Million |
|---|---|
| Enterprise Value | $107.32 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.59 |
| Beta | -0.14 |
| Outstanding Shares | 187,070,510 |
| P/E Ratio | -17.78 |
|---|---|
| PEG | 54.32 |
| Price to Sales | - |
| Price to Book Ratio | 5.28 |
| Enterprise Value to Revenue | 1.31 |
| Enterprise Value to EBIT | -0.73 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 0.03 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
CM Life Sciences II Inc. is a blank check company formed for the purpose of effecting a business combination. The Company intends to focus its search for business combination targets in three separate areas of the life sciences industry ...